AccuStem Sciences, Inc.
ACUT
$0.277
$0.000.00%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 74.86% | 33.43% | 65.42% | -5.41% | -80.04% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 12.50% | 28.57% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.82% | -47.63% | -66.49% | 152.51% | 184.83% |
| Change in Net Operating Assets | -122.22% | -25.84% | -516.54% | -70.28% | -40.61% |
| Cash from Operations | 52.60% | 36.68% | 47.74% | -219.92% | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 616.19% | 8,468.09% | 885.16% | -- | -- |
| Total Debt Repaid | -172.49% | 6.06% | 76.16% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 910.29% | 420.25% | 278.18% | -103.72% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 91.72% | 92.36% | 95.25% | -117.05% | -- |
